drugset / Trial / NCT05815784

Myopia Control: a Comparison Study Between Atropine and MiSight

NCT05815784

Phase 2 Recruiting 348 enrolled Ann & Robert H Lurie Children's Hospital of Chicago
Non-randomizedParallel-groupOpen-labelTreatment

Summary

This research project aims to provide additional knowledge of pharmacological and optical methods of myopia control and to gain a better understanding of the biometry of the pediatric eye, which contributes to the onset and progression of myopia. As a result, this study will improving our best practices for myopia control in pediatric patients.

Timeline

Start
2023-05-02
Primary completion
2026-03-13
Completion
2026-03-13

Drugs

EvaluationDrugModalityDoseRoute
Subject Atropine Other / unclassified 0.05 % Topical

Indications